Vera Therapeutics, Inc. (VERA)
34.35
-0.27
(-0.78%)
USD |
NASDAQ |
May 21, 16:00
34.35
0.00 (0.00%)
After-Hours: 19:59
Vera Therapeutics Research and Development Expense (TTM) : 259.47M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Cogent Biosciences, Inc. | 277.48M |
| Syndax Pharmaceuticals, Inc. | 255.98M |
| United Therapeutics Corp. | 539.20M |
| Biogen, Inc. | 1.607B |
| Cytokinetics, Inc. | 400.51M |